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0014-5793  2012 Federation of European BiochemicRNA polymerase II backtracking is a well-known phenomenon, but its involvement in gene regula-
tion is yet to be addressed. Structural studies into the backtracked complex, new reactivation mech-
anisms and genome-wide approaches are shedding some light on this interesting aspect of gene
transcription. In this review, we brieﬂy summarise these new ﬁndings, comment about some results
recently obtained in our laboratory, and propose a new model for the inﬂuence of the chromatin
context on RNA polymerase II backtracking.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V.1. Introduction
RNA polymerase II plays a key role in the expression of eukary-
otic genomes. All protein-encoding genes are transcribed by this
polymerase, whose structural and functional properties enable
the great diversity of regulatory programs that are executed
throughout the genome. The best-known regulation mechanisms
operate during pre-initiation complex assembly and initiation,
but a signiﬁcant number of genes regulate their transcription in
post-initiation steps (reviewed in [1]). Among others, the mecha-
nisms sustaining elongation should provide the opportunity to reg-
ulate transcription.
Transcription elongation is far from a uniform process. RNA
polymerase II proﬁles, measured by chromatin immunoprecipita-
tion (ChIP), transcriptional run-on or nascent RNA sequencing have
established clear differences between genes within the same gen-
ome [2–5]. Single-cell experiments have also shown that RNA
polymerase II progression along a transcribed gene is a discontin-
uous process which combines short advances with pauses of a var-
iable time extent [6]. All these results demonstrate that pausing isedes 6, E41012 Seville, Spain.
al Societies. Published by Elseviera frequent phenomenon that is likely consubstantial to RNA poly-
merase II-dependent transcription.
In vitro experiments have demonstrated that RNA polymerase II
pausing is a highly unstable state which results in either forward
transcription or stable arrest [7]. RNA polymerase II arrest involves
backtracking, a reverse movement that brings about loss of contact
between the 30 end of nascent RNA and the RNA polymerase II ac-
tive site. As a result of this mislocalisation, backtracked RNA poly-
merases cannot resume transcription immediately. The ternary
complex formed by DNA, RNA and backtracked RNA polymerase
II is extremely stable. Recent structural data published by Cramer’s
lab explain this stability by the speciﬁc binding of eight nucleotides
of backtracked RNA to a highly conserved site in the RNA polymer-
ase II pore and funnel, which traps a protein loop located in the ac-
tive site [8].
In vivo and in vitro studies have found a large number of causes
which bring about RNA polymerase II arrest. The scarcity of nucle-
otides favours RNA polymerase II arrest in vitro. Drugs that pro-
voke depletion of NTP pools, like 6-azauracil and mycophenolic
acid, lower the elongation rate and the processivity of RNA poly-
merase II in vivo [9], which increases frequency of arrest [10].
Yeast mutants lacking RNA polymerase II reactivation factors, like
TFIIS or Ccr4-Not (see later), exhibit hypersensitivity to these NTP-
depleting drugs.B.V. Open access under CC BY-NC-ND license.
Fig. 1. Mechanisms resolving RNA polymerase II backtracking. RNA polymerase II
backtracking involves the relocation of the 30 end of nascent RNA outside the active
site. This can be solved spontaneously by the intrinsic RNA cleavage activity of the
enzyme (a) but it gets strongly stimulated by TFIIS (b). Alternatively Ccr4, a subunit
of the Ccr4-Not complex, can stimulate forward-tracking, thus allowing RNA
polymerase II to resume elongation in an RNA cleavage-independent manner (c).
Arrested RNA polymerase II can be removed from DNA by ubiquitylation and its
subsequent degradation by the proteasome (d). The ternary complex formed by
DNA, RNA and the backtracked RNA polymerases might also be disassembled,
involving transcription termination (e). However no clear experimental evidence is
available for this mechanism.
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ence of obstacles in DNA. Among them, nucleosomes are the most
ubiquitous structures to hinder eukaryotic transcription. In vitro
studies have clearly shown that nucleosomes promote backtrack-
ing and that transcription of nucleosomal templates is stimulated
by TFIIS, this being the RNA cleavage factor that reactivates back-
tracked RNA polymerase II [11](see later).
Transcription elongation generates torsional stress on DNA,
which needs to be removed by toposiomerases [12]. This accumu-
lation of positive supercoiling is particularly detrimental for tran-
scription elongation through yeast genes longer than 3 kpb [13].
Topological constrains is, therefore, another potential source of
RNA polymerase II stalling. Interestingly, the impact of DNA tor-
sional stress on transcription is conditioned by the chromatin orga-
nisation of the transcription unit, in a double way. On one hand,
chromatin compaction facilitates RNA polymerase II elongation
[14]; on the other hand, nucleosome free regions facilitate topoiso-
merase II recruitment to transcribed genes [15].
DNA lesions are cause of RNA polymerase arrest as well. Bulky
DNA adducts within transcribed regions lead to RNA polymerase
II arrest. In most cases this arrest is irreversible and needs to be
solved by the degradation of the stalled polymerase (reviewed in
[16]). Undamaged DNA sequences can also favour RNA polymerase
II arrest in vitro, even when the template takes a non-nucleosomal
conﬁguration [17]. Pyrimidine-rich tracks in the non-template
strand, like the TTTTTTTCTCCATTTT sequence present in the intrin-
sic ‘‘terminator’’ region within the c-myc ﬁrst exon–intron bound-
ary, induce RNA polymerase II arrest [18]. This sequence-
dependent arrest was ﬁrst explained by the results of the weak
DNA–RNA interactions caused by the high proportion of U = A
pairs. Later, however, results indicate that the presence of cyto-
sines in the polypyrimidine track is not detrimental for arrest
[19]. This is in good agreement with the strong preference for
pyrimidines found in the speciﬁc interaction between backtracked
RNA and the ‘‘backtracked site’’, in the RNA polymerase II pore and
funnel [8]. This sequence speciﬁcity establishes the basis for an
arresting code across the genome, which might explain the biased
distribution of the polypyrimidine/polypurine tracks between tem-
plate and non-template strands [20].
2. Molecular mechanisms overcoming RNA polymerase II arrest
RNApolymerasearrest cannotbepermanent, since thiswould in-
volve the complete repression of gene expression and would seri-
ously hinder DNA replication, leading to genome instability and
eventually to cell death (reviewed in [16]). Even in those caseswhere
RNA polymerase arrest plays a role in gene regulation, the mecha-
nisms capable of resuming transcription or removing arrested poly-
merase are required for transcription cycle viability. Three different
mechanisms operating in arrested RNA polymerase II have been de-
scribed: RNA cleavage, allowing the RNA 30 end to relocate at the ac-
tive site; reversion of the backtracked state by the forward
movement of the polymerase; and eviction of arrested RNA poly-
merase II by ubiquitylation-mediated degradation (Fig. 1).
Endonucleolytic activity allows 30 RNA cleavage, which is an
inherent property of RNA polymerase II that becomes highly stim-
ulated by cleavage factor TFIIS [21]. The structural basis for TFIIS-
assisted RNA cleavage has been recently explained [8]. TFIIS do-
main III extends into the RNA polymerase II pore, reaching the ac-
tive site and remodels the RNA polymerase II motifs that bind
backtracked RNA. This enables the displacement of RNA from the
backtracked site. In addition, TFIIS complements the active site
with several residues that may catalyze proton transfers during
RNA cleavage [8].
Even in the absence of TFIIS, arrested RNA polymerase II can be
reactivated by RNA cleavage. This has been elegantly shown bySvesjtrup’s lab using a dominant negative TFIIS mutant that can
bind arrested RNA polymerase II without stimulating RNA cleav-
age. The resulting ternary complex stabilises the backtracked con-
ﬁguration by inhibiting spontaneous RNA cleavage [22]. The lethal
phenotype of this mutant in yeast, unlike the viability of the TFIIS
deletion mutant, indicates that RNA polymerase II arrest is a very
common phenomenon which yeast cells under standard growing
conditions can solve by either spontaneous or TFIIS-stimulated
RNA cleavage, or even by alternative mechanisms.
One of these alternative mechanisms is mediated by Ccr4-Not.
This is an evolutionarily conserved complex composed of nine sub-
units. Based on independent experimental approaches, Ccr4-Not
has been connected to different aspects of gene transcription,
including initiation [23,24] and elongation [2,25,26]. Ccr4 is the
major cytoplasmic mRNA deadenylase in yeast and the complex
localises to processing bodies where mRNA degradation takes
place [27,28]. In this multifunctionality context, Reese’s lab has
demonstrated that Ccr4-Not stimulates transcription elongation
by promoting the resumption of elongation by arrested polymer-
ases [29]. The interaction of Ccr4-Not with the emerging transcript
is required for this way of reactivating arrested RNA polymerase II,
which does not involve RNA cleavage (Fig. 1).
The described reactivation mechanisms are likely to overcome
most RNA polymerase II arrest events, but cells have an additional
way of contending with irreversibly blocked transcriptional com-
plexes, namely degradation [30,31]. This mechanism involves
ubiquitylation of the biggest RNA polymerase II subunit, Rpb1, at
different sites in a process that is speciﬁcally mediated by the ubiq-
uitylation factor Def1 and the CTD domain of Rpb1 [32]. Mutations
affecting Rpb1 ubiquitylation and RNA cleavage are synthetic
lethal, indicating that RNA cleavage or degradation are the only
possible alternatives, at least for a subset of arrested RNA polymer-
ase II molecules [32]. In addition to the proteasome-dependent
degradation of RNA polymerase II, Rpb1 ubiquitylation might also
promote other alternative resumption processes prior to degrada-
tion (see the discussion of this issue in [33]). In light of this, it is
meaningful that Def1 is an interacting factor of Rad26, a DNA heli-
case involved in transcription-couple repair, which inhibits RNA
polymerase II degradation [34]. A scenario, in which Rpb1 ubiqui-
tylation promotes the disassembly of arrested RNA polymerase II
in a helicase-assisted way, is an attractive possibility that remains
to be experimentally tested (Fig. 1).
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Transcriptional regulation in post-initiation stages is a common
phenomenon across metazoan genomes. At least 40% of genes
show promoter-proximal accumulation of RNA polymerase II in
mammalian, Drosophila and Caenorhabditis cells [3,35–39].
An example of regulation at the level of elongation is found in
the so-called bivalent genes in embryonic stem cells. They display
characteristic chromatin markers of silenced (histone H3K27 tri-
methylation) and active transcription (histone H3K4 tri-methyla-
tion)[40]. A subgroup of bivalent genes, bound by Polycomb
repressive complex 2, displays stalled RNA polymerase II. Since sta-
ble pausing leads to RNA polymerase II arrest, it is likely that the
RNA polymerase II molecules present in silenced bivalent genes
are arrested; however, there is no direct experimental evidence
for this hypothesis. Such evidence actually exists for another group
of mammalian genes which exhibit promoter-proximal accumula-
tion of RNA polymerase II. Growth-promoting, pro-oncogenic
genes like FOS andMYC reside preferentially in compact chromatin
and are inefﬁciently transcribed under basal conditions. The tran-
scription of these genes is repressed during early elongation by a
mechanism interfering with TFIIS recruitment that involves H2B
ubiquitylation [41].
The involvement of TFIIS is also demonstrated in the activation,
in response to heat shock, of the stalled RNA polymerases occupy-
ing the promoter proximal region of Drosophila Hsp70 [42]. Using
RNA interference, in vivo TFIIS depletion provokes a delay in Hsp70
induction which, in this case, is only possible after a new round of
transcription initiation [42]. Accordingly, we can conclude that
most, if not all, stably stalled RNA polymerases would be back-
tracked and would require TFIIS or any alternative reactivation
mechanism to recover the elongation capability upon activation.
One direct way of detecting backtracked RNA polymerases is to
compare the genomic patterns of run-on signals, which reﬂect
elongation-proﬁcient RNA polymerases [43], with the genomic dis-
tribution of the total RNA polymerase II measured by ChIP. This
strategy detected clear differences between the two patterns
across the yeast genome [44]. There is a general high correlation
between run-on and ChIP signals, but some gene ontology catego-
ries exhibit lower run-on values than expected according to their
ChIP signals [44]. This difference proves particularly striking for
those genes encoding ribosomal proteins (RP), indicating the accu-
mulation of backtracked RNA polymerase II in these genes. One
particular behaviour of RNA polymerase II during transcription
elongation of RP genes is also reﬂected by the 50-biased distribu-
tion of the run-on signals in this speciﬁc group of genes [2]. This
bias was also observed in the distribution of nascent RNA of highly
expressed genes across the yeast genome [5]; the high proportion
of highly transcribed genes belonging to the RP group might ex-
plain this result.
The run-on signals of RP genes lowered when comparing yeast
cells exponentially growing in glucose-containing medium to cells
exponentially growing in galactose-containing medium. However,
this decrease was signiﬁcantly more marked in the total RNA poly-
merase II levels detected by ChIP than in the run-on signals;
accordingly, the run-on/ChIP ratio for the RP genes increased from
glucose to galactose (Fig. 2). The nuclear genes encoding mitochon-
drial components exhibited the opposite change (Fig. 2) [44]. The
simplest interpretation of these results involves a speciﬁc reduc-
tion in the number of backtracked RNA polymerase II complexes
in response to the carbon source (Fig. 2). In fact, the run-on/ChIP
ratio of RP genes depends on the integrity of the Ras-PKA pathway
and on the silencing domain of Rap1, an essential transcription fac-
tor for RP genes transcription [44]. In short, these observations sug-
gest that RNA polymerase II backtracking is an important elementin the transcriptional regulation of RP genes and of other gene fam-
ilies across the yeast genome.
A regulatory mechanism based on RNA polymerase II backtrack-
ing, for constitutively expressed genes like RP, must involve an efﬁ-
cient reactivation mechanism. A series of experiments carried out
in our laboratory demonstrate that TFIIS is particularly involved
in the reactivation of backtracked RNA polymerase II on RP genes,
at least under the strong transcriptional stress caused by 6AU [45].
Shortly after adding this drug to yeast cells, RNA polymerase II
complexes transcribing the RP genes become enriched in TFIIS, in
comparison to the other highly transcribed genes tested, which
do not relate to ribosomes (Fig. 3A). This difference between RP
and non-RP genes is particularly striking in the 50 end of the tran-
scribed region, where RNA polymerase II accumulates upon NTP
depletion [9]. RP genes maintain high TFIIS/Rpb3 ratios in 50 upon
6AU treatment, whereas in non-RP genes RNA polymerase II shifts
towards the 50 region while TFIIS does not, resulting in low TFIIS/
Rpb3 ratios (Fig. 3A). The low TFIIS demand by paused RNA poly-
merase II in non-RP genes anticipates a lower level of backtracking
than in RP genes, which is conﬁrmed by the transcriptional run-on
assays (Fig. 3B). In fact, the comparison of wild-type and dst1D
(TFIIS-deleted) strains shows that the run-on/RNA polymerase II
ChIP ratios of RP genes in the presence of 6AU are strictly depen-
dent on TFIIS, whereas the effect of 6AU on non-RP genes’ run-
on/RNA polymerase ChIP ratios is much milder and does not de-
pend on TFIIS to a similar extend (Fig. 3B).
We have also showed that this high dependence of yeast RP
gene transcription on TFIIS can be suppressed by deleting genes
encoding transcriptional regulators of RP gene expression, like
Sfp1 [45]. In the absence of Sfp1, RP genes do not depend on TFIIS
to maintain active elongating RNA polymerase molecules on their
gene bodies (Fig. 3B). Moreover, the absence of Sfp1 suppresses
RNA polymerase II accumulation on the 50 end in all tested genes,
suggesting that this protein plays a general role in promoting RNA
polymerase II pausing [45].
By way of conclusion, the speciﬁc regulation imposed by factors
like Sfp1 to yeast RP genes during elongation, involving RNA poly-
merase II backtracking, makes this group of genes more dependent
on reactivation factors, like TFIIS, to resist transcriptional stress.
4. Backtracking in the chromatin context
The mechanism explaining this differential tendency of RNA
polymerase II to backtrack is unknown. It may be due to a differen-
tial composition of RNA polymerase II elongation machinery,
thereby imposing different modes of transcription to speciﬁc genes
or regulons. A biased composition of RNA polymerase II itself is an
appealing hypothesis. The Rpb4/7 submodule has been shown to
drop easily from RNA polymerase II in vitro and to play indepen-
dent roles in vivo [46]. rpb4D mutants display synthetic lethality
with dst1D, lacking TFIIS, and are extremely sensitive to NTP-
depleting drugs [26,47]. It would be, therefore, conceivable that
in some genes RNA pol II was prone to backtracking as a result of
a premature drop of Rpb4/7 during elongation. Experimental data,
however, do not support this hypothesis so far. The Rpb3/Rpb7 ra-
tio is largely invariable across the yeast genome [48]. Moreover,
the composition of the whole RNA polymerase elongation machin-
ery is largely constant for all yeast genes [49], suggesting that the
differential backtracking behaviour is likely due to transcribed
genes rather than to transcriptional machinery.
In contrast, chromatin is markedly polymorphic across the gen-
ome and nucleosome positioning is not uniform. Yeast RP genes,
for instance, show shorter nucleosome repeat than non-RP genes
[50]. Histone variants and chromatin covalent modiﬁcations also
display gene-to-gene variation across the genome [51]. Accord-
Fig. 2. The proportion of active, run-on-competent RNA polymerase II is regulon-speciﬁc and controlled by the yeast cell in response to physiological stimuli. Yeast ribosomal
protein genes show a signiﬁcant proportion of elongating RNA polymerase II molecules that do not produce a transcriptional run-on signal (red) when exponentially growing
in glucose-containing medium. The same genes, when cells are exponentially growing in galactose-containing medium, show lower levels of elongating RNA polymerase II
but exhibit a much higher proportion of run-on competent enzymes (green). The yeast genes encoding mitochondrial elements exhibit the opposite regulation: low
proportion of active polymerase in galactose medium and high proportion, although limited levels, in glucose medium. Most of yeast genes do not exhibit a signiﬁcant
proportion of run-on-incompetent cells under either of the two growth conditions. Adapted from the experimental data described in [44].
Fig. 3. TFIIS is required particularly to maintain RNA polymerase II activity on ribosomal protein genes under transcriptional stress. A. A 15 min 6AU treatment causes a 50-
shift in the distribution of RNA polymerase II along the transcribed region in wild-type yeast cells. At the same time, RP genes decrease at the absolute levels of RNA
polymerase II, which reﬂects their down-regulation in response to the growth impairment caused by the drug. TFIIS distribution parallels that of RNA polymerase II in RP
genes. In non-RP genes, TFIIS does not undergo the 50-shift of RNA polymerase II upon 6AU treatment. B. Comparison of the wild-type and dst1D run-on patterns allow us to
conclude that RP genes require TFIIS to maintain the activity of their RNA polymerase molecules upon 6AU addition. Non-RP genes show a much milder dependence on TFIIS
under the same conditions. This differential behaviour of RP and non-RP genes depends on regulatory factor Sfp1. In both sfp1D and sfp1D dst1D cells, RNA polymerase
activity and intragenic distribution are not inﬂuenced by 6AU. Adapted from the experimental data described in [45].
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merase II and the gene-speciﬁc conﬁguration of chromatin might
explain its differential tendency to backtrack. If this hypothesis
were true, elongation through some chromatin conﬁgurations
would take place without backtracking, whereas other alternative
chromatin conﬁgurations would be highly prone to backtracking.
In the latter, TFIIS would be highly demanded. In vitro experiments
performed in Kashlev’s laboratory have shown that TFIIS is indeed
required for RNA polymerase II to overcome the strong stalling im-
posed by a nucleosome, whereas the same DNA template, when
naked, does not promote RNA polymerase II pausing or requires
TFIIS [52]. The combination of TFIIS and TFIIF, another general tran-
scription factor that stimulates elongation, synergistically stimu-
late nucleosome transcription by RNA polymerase II [53].
In these latter experiments, nucleosome traversal by RNA poly-
merase II took place without nucleosome displacement. Studitsky’s
laboratory has shown that nucleosomes can indeed survive tran-
scription in vitro, by allowing the formation of an intranucleosomal
DNA loop (Ø loop) that contains the transcribing enzyme [54]. ThisØ loop likely requires speciﬁc DNA-histone interactions, since his-
tone Sin mutations, disrupting this kind of interactions, compro-
mise nucleosome survival during elongation [55].
Recent results obtained by atomic force microscopy also indi-
cate that RNA polymerase II can transcribe a nucleosome without
promoting its complete disassembly, but just removing a single
H2A-H2B dimer [56]. A similar conclusion was obtained by analys-
ing the fate of nucleosomal histones during in vitro transcription: a
remodelled nucleosome, depleted of a single H2A-H2B dimer by
histone chaperone Nap1 action, can be transcribed without com-
plete histone eviction [57]. In agreement with these results, his-
tone hexasomes (a H3-H4 tetramer associated to a single H2A-
H2B dimer in the context of a remodelled nucleosome [58]) have
long since been related to transcribed chromatin [59].
In this emerging model, RNA polymerase II would be able to
elongate transcription along a nucleosomal DNA template by tak-
ing advantage of the Ø loop that the missing H2A-H2B dimer
would provoke within the nucleosome. It is difﬁcult to imagine
such a way of transcribing nucleosomal DNA as a continuous run,
Fig. 4. Different modes of transcription elongation through chromatin may explain gene-speciﬁcity in RNA polymerase II backtracking. Transcription of chromatin without a
complete nucleosome disassembly would favour RNA polymerase II backtracking, involving higher dependency on TFIIS and other arrest-solving factors. Full histone eviction
during transcription elongation would prevent RNA polymerase backtracking. The ﬁrst chromatin transcription mode would require H2A-H2B handling factors like Nap1,
necessary to remove a single H2A-H2B dimer and to form the remodelled hexameric nucleosome (hexasome) that is competent for elongation. The eviction-dominated mode
would require H3-H4 chaperons. Regulatory factors would control RNA polymerase II backtracking by modulating the predominance of these two alternative elongation
modes in any gene.
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transcription elongation and histones-DNA reconﬁguration steps
around the nucleosome. In this context, frequent RNA polymerase
II backtracking would be expected (Fig. 4). A comparison made of
the massive sequencing of nascent RNA with high resolution nucle-
osome positioning showed a paused distribution of elongating RNA
polymerase II within nucleosomes [60], which is consistent with
this hypothesis. In contrast, a transcriptional elongation mode
dominated by histone eviction and complete nucleosome disas-
sembly might prove more similar to in vitro naked DNA transcrip-
tion and, therefore, might be less prone to backtracking, and less
TFIIS-dependent (Fig. 4).
Gene-speciﬁcity in backtracking might arise from these alterna-
tive modes of transcription elongation. In some cases, as in the RP
regulon, the hexasome-mediated, TFIIS-dependent elongation of
nucleosomal DNA would be dominant. In other cases, such as
SAGA-dependent inducible genes, complete histone eviction would
be dominant and transcription elongation would depend much less
on TFIIS and be less prone to backtracking. The observation of posi-
tioned nucleosomal proﬁles beingmore resistant to transcription in
RP genes than in SAGA-dependent genes supports this model [51].
The existence of two alternative modes of transcription elonga-
tion, depending on the chromatin context, can help explain the via-
bility of yeast mutants lacking TFIIS. In them, the histone eviction
mode would rescue RNA polymerase II from general arrest. In this
context, those regulatory mechanisms promoting the hexasome-
mediated mode would enhance the dependence of RNA polymer-
ase II on TFIIS and other reactivating factors. Factors like yeast
Sfp1 ﬁt in this regulatory role (Fig. 4).
5. Remarks
RNA polymerase II pausing during elongation is a common phe-
nomenon. The connection between pausing and backtracking dem-
onstrated in vitro and the involvement of TFIIS in the regulation of
some genes during elongation suggest that RNA polymerase II
backtracking is likely an important element in eukaryotic gene
control. The conserved motives involved in stabilising backtracked
RNA inside RNA polymerase II match this general backtracking role
in gene regulation.
The comparisons made between the run-on and RNA polymer-
ase II ChIP proﬁles in yeast are compatible with a signiﬁcant pro-
portion of backtracked RNA polymerases in certain gene families;
e.g., RP genes. The transcriptional regulation of RP genes, in re-
sponse to changes in the carbon source of the medium, involves
changes in the proportion of backtracked RNA polymerases. This
regulatory mechanism is mediated by transcription factor Rap1.Backtracking requires either reactivation or RNA polymerase II
removal mechanisms. Reactivation can be achieved by RNA cleav-
age, a process that is strongly stimulated by TFIIS. Reactivation can
also be mediated by the Ccr4-Not complex in a process that does
not involve RNA cleavage. For RP genes, TFIIS is required to resist
the transcriptional stress imposed by NTP-depleting drugs like
6AU. This requirement depends on the regulatory programme im-
posed by speciﬁc transcription factors, like Sfp1.
Whatmakes some genes particularly prone to RNApolymerase II
backtracking remains unknown, but the emergingmodels proposed
to explain chromatin transcriptionmay help shed some light on this
phenomenon. The precise characterisation of themechanisms regu-
lating RNA polymerase II backtracking is, therefore, one of the forth-
coming challenges in the transcription research ﬁeld.
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